Cardiovascular diseases remain a leading cause of mortality worldwide, driving an urgent need for innovative therapies that improve both quality and longevity of life. At mediSMART, we are committed to advancing cardiovascular health by supporting the development of cutting-edge treatments through high-quality clinical research.

Our team actively conducts phase I–IV clinical trials across a broad spectrum of cardiovascular indications, including:

❤️ Heart failure

🩺 Hypertension

🫀 Atherosclerosis

⚡ Acute coronary syndromes (ACS)

💔 Ischemic heart disease

🦵 Peripheral artery disease (PAD)

📈 Arrhythmias and atrial fibrillation

🧪 Hyperlipidemia and dyslipidemia

Backed by a robust network of cardiology investigators, dedicated study coordinators, and a strong operational infrastructure, mediSMART ensures efficient patient recruitment, regulatory adherence, and reliable data delivery across Turkey and the MENA region.

By partnering with global sponsors and CROs, we help bring life-saving cardiovascular therapies to patients faster—contributing to a healthier future for all.